Αποτελέσματα Αναζήτησης
20 Αυγ 2021 · This guideline covers obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS), and chronic obstructive pulmonary disease (COPD) with OSAHS overlap syndrome, providing advice on investigating and managing these related conditions.
Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass index ≥30 kg·m −2), daytime hypercapnia (arterial carbon dioxide tension ≥45 mmHg) and sleep disordered breathing, after ruling out other disorders that may cause alveolar hypoventilation.
1 Νοε 2020 · CPAP is simpler to implement and is less costly than NIV. 24 To investigate which of the two treatments is more cost-effective, the only study reported is from Masa and cols, whom carried out a post hoc, within-trial, cost-effectiveness analysis using the large multicentre, open-labelled, randomised controlled study (Pickwick study) 3, 24, 43 ...
Obesity hypoventilation syndrome (OHS) may be suspected when symptoms lead to pulmonary or sleep consultation in stable conditions as an outpatient or during an episode of hospitalization due to acute-on-chronic hypercapnic respiratory failure.
Background Obesity hypoventilation syndrome (OHS) is treated with either non-invasive ventilation (NIV) or CPAP, but there are no long-term cost-effectiveness studies comparing the two treatment modalities.
The main sleep-related breathing disorders associated with obesity are obstructive sleep apnoea/hypopnoea syndrome (OSAHS) and obesity hypoventilation syndrome (OHS). 1 Patients with OHS always have a body mass index (BMI) ≥30 mg/kg 2.
Clinical features to assess such risk include severe obesity with typical signs and symptoms of obstructive sleep apnea (OSA)/OHS and mild hypoxemia while awake, significant hypoxemia during sleep, or both.
